Amount Raised
$2.8 Million
Round Type
Seed
San CarlosBiotechnologyHealth CareTherapeuticsDescription
Apexigen, Inc. (Nasdaq: APGN), a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced that it has entered into definitive agreements with new, biotechnology-focused investors for the issuance and sale of an aggregate of approximately 2.0 million shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of approximately 2.0 million shares of common stock in a private placement offering. The purchase price per share and accompanying warrant is $1.40 (or $1.399 per pre-funded warrant and accompanying warrant). The warrants have an exercise price of $1.40 per share and will expire 5 years from the effective date of the registration statement that will be filed in connection with the private placement.
Quick answer
Apexigen raised $2.8 Million in a Seed round, dated January 24, 2023. Apexigen is based in San Carlos, California, United States.
- How much did Apexigen raise?
- Apexigen raised $2.8 Million in a Seed round on January 24, 2023.
- What does Apexigen do?
- This platform has enabled Apexigen and its collaboration partners to discover and develop therapeutic antibodies against a variety of molecular targets, including targets that are difficult to drug with conventional..
- Where is Apexigen based and how big is it?
- Apexigen is based in San Carlos, California, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Apexigen that raised within 45 days of this round, from Fundz verified event records.
- Virax Biolabs raised $4M on March 10, 2023.
- QurAlis raised $88M (Series B) on March 9, 2023.
- GenoME Diagnostics raised $1.8M (Seed) on March 3, 2023.
- Chroma Medicine raised $135M (Series B) on March 1, 2023.
- Wilson Wolf Manufacturing raised an undisclosed amount on March 1, 2023.
- Aprea Therapeutics raised an undisclosed amount (Funding Round) on February 28, 2023.
Who to call at Apexigen, and when
A new round usually means Apexigen is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Apexigen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Apexigen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Apexigen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Apexigen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Apexigen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.